Amyotrophic Lateral Sclerosis (ALS), also known as Lou Gehrig’s disease, is a progressive neurodegenerative disorder that affects the motor neurons responsible for controlling voluntary muscle movements. This condition gradually impairs the brain's ability to initiate and control muscle actions, impacting functions such as speaking, swallowing, and breathing. ALS affects about 2-5 out of every 100,000 people globally, with the majority of cases being sporadic and around 5-10% linked to genetic factors^[1,2].

Symptoms of ALS

ALS symptoms vary widely between individuals, depending on which motor neurons are affected first. Over time, these symptoms worsen, leading to more extensive loss of muscle control. Common symptoms include:

• Muscle Weakness: Initial weakness, often starting in one hand, leg, or limb, and may spread asymmetrically^[3].
• Muscle Cramps and Twitching: Especially in the hands, feet, shoulders, and tongue, which may be early indicators^[4].
• Difficulty Speaking and Swallowing: Slurred speech and difficulties in swallowing (dysphagia) can occur as ALS progresses^[5].
• Loss of Coordination and Mobility: Gradual loss of motor skills, often causing difficulty with daily activities.
• Breathing Complications: As respiratory muscles weaken, breathing becomes increasingly difficult, necessitating medical intervention^[6].

Causes of ALS

ALS has both genetic and environmental factors, though the exact cause remains largely unknown^[7].

1. Genetic Factors: Roughly 5-10% of ALS cases are familial, linked to inherited mutations in genes such as SOD1, C9orf72, and FUS. These mutations disrupt normal motor neuron function and lead to degeneration^[8].

2. Environmental Triggers: Research suggests certain environmental factors may increase ALS risk, including:

   • Toxin Exposure: Possible exposure to certain chemicals or pesticides^[9].
   • Heavy Metal Exposure: Particularly in individuals exposed to lead or other toxic metals^[10].
   • Military Service: Veterans have a slightly higher risk of developing ALS, though reasons remain unclear^[11].

3. Lifestyle Factors: Smoking, strenuous physical activity, and head trauma may increase susceptibility^[12,13].

Current Treatment Options

While there is no cure for ALS, several treatment options focus on slowing disease progression, managing symptoms, and improving quality of life^[14,15].

Medications

• Riluzole: The most widely used ALS medication, riluzole works by reducing glutamate activity, potentially slowing disease progression^[16].
• Edaravone (Radicava): An antioxidant that may slow functional decline in ALS patients by reducing oxidative stress on neurons^[17].

Respiratory Support

• Non-Invasive Ventilation (BiPAP): Helps support breathing, especially during sleep, to improve oxygen levels^[18].
• Tracheostomy and Mechanical Ventilation: For advanced ALS, patients may require more intensive respiratory support^[19].

Physical and Occupational Therapy

• Physical Therapy: Exercises and mobility aids can help ALS patients retain muscle strength and flexibility, improving comfort and mobility^[20].
• Occupational Therapy: Focuses on adaptations to help patients carry out daily tasks and maintain independence as long as possible^[21].

Speech and Swallowing Therapy

• Speech Therapy: For patients experiencing speech difficulties, assistive communication devices may be helpful^[22].
• Swallowing Therapy: Techniques to improve swallowing safety, and in advanced cases, the use of a feeding tube can ensure nutritional needs are met^[23].

Nutritional Support

• Dietary Interventions: A dietitian can help ALS patients maintain weight and nutrition, which is crucial as swallowing becomes more challenging^[24].

Stem Cell Therapy (Emerging)

• Stem cell research in ALS is exploring the potential to regenerate damaged motor neurons. While still experimental, certain therapies are under investigation for their potential to slow ALS progression and improve motor function^[25,26].

Treatment Options at Beijing Puhua International Hospital

Beijing Puhua International Hospital offers an integrative approach for ALS patients, combining advanced neurological care, supportive therapies, and emerging treatments. The hospital provides:

1. Medication Management

   • Latest ALS medications, including Riluzole and Edaravone, to manage symptoms and potentially slow disease progression.

2. Advanced Rehabilitation Programs

   • Comprehensive physical, occupational, and speech therapy to help manage symptoms, enhance mobility, and improve quality of life.
   • Techniques and support for speech and swallowing to maintain communication and nutritional intake.

3. Respiratory Support

   • Non-invasive ventilation options like BiPAP to support breathing and improve sleep quality.
   • Advanced respiratory care for patients requiring mechanical ventilation.

4. Nutritional and Dietary Support

   • Customized dietary plans to optimize nutrition, with support for feeding tube placement when necessary.

5. Traditional Chinese Medicine (TCM) Integration

   • Acupuncture and herbal therapies for pain relief, stress management, and overall well-being.

Outlook for ALS Patients

ALS remains a challenging condition without a cure, but significant strides have been made in understanding and managing the disease. By focusing on symptom management, quality of life, and ongoing research into potential therapies like stem cell treatment, the outlook for ALS patients continues to evolve.

References

1. Kiernan MC, Vucic S, Cheah BC, et al. "Amyotrophic lateral sclerosis." The Lancet. 2011.

2. Rowland LP, Shneider NA. "Amyotrophic lateral sclerosis." New England Journal of Medicine. 2001.

3. Mitchell JD, Borasio GD. "Amyotrophic lateral sclerosis." The Lancet. 2007.

4. Swash M, Desai J. "Motor neuron disease: classification and nomenclature." Amyotrophic Lateral Sclerosis. 2000.

5. Hardiman O, et al. "Amyotrophic lateral sclerosis." The Lancet. 2017.

6. Van Damme P, et al. "ALS and breathing support." Journal of the American Medical Association. 2009.

7. Chen H, Richard M, Sandler DP, et al. "Head injury and amyotrophic lateral sclerosis." American Journal of Epidemiology. 2007.

8. Renton AE, et al. "ALS genetics and causation." Nature Neuroscience. 2014.

9. Morozova N, et al. "Pesticide exposure as a risk factor for ALS." Environmental Health Perspectives. 2009.

10. Johnson FO, Atchison WD. "Heavy metal exposure and ALS." Neurotoxicology. 2009.

11. Horvath MM, et al. "ALS and military service correlation." Military Medicine. 2011.

12. Weisskopf MG, et al. "Cigarette smoking and ALS risk." Annals of Neurology. 2004.

13. Turner MR, et al. "Head trauma and ALS." Journal of Neurology, Neurosurgery & Psychiatry. 2010.

14. Logroscino G, Traynor BJ, et al. "Drug treatment efficacy for ALS." Brain. 2008.

15. Miller RG, et al. "Pharmacological treatment of ALS." Neurology. 2009.

16. Bensimon G, et al. "Riluzole for ALS." The New England Journal of Medicine. 1994.

17. Abe K, et al. "Efficacy of edaravone in ALS." Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. 2017.

18. Dreyer PS, et al. "Respiratory management in ALS." Journal of Clinical Medicine. 2019.

19. Chatwin M, et al. "Mechanical ventilation in ALS." Journal of Neurology, Neurosurgery & Psychiatry. 2018.

20. Lechtzin N, et al. "ALS physical therapy." Physical Therapy. 2002.

21. Bedlack RS, et al. "Occupational therapy for ALS patients." Journal of Clinical Neuromuscular Disease. 2003.

22. Ball L, et al. "Speech therapy and ALS." ALS Association Journal. 2014.

23. Gregory S, et al. "Swallowing therapy in ALS." Journal of Clinical Neurology. 2016.

24. Paris G, et al. "Nutritional support in ALS." Nutrition in Clinical Practice. 2013.

25. Nathalie H, et al. "Stem cell therapies for ALS." Stem Cells International. 2021.

26. Glass JD, et al. "ALS treatment with stem cells." Journal of the Neurological Sciences. 2012.

Overview

Parkinson's Disease (PD) is a progressive neurodegenerative disorder characterized by the degeneration of dopamine-producing neurons in the brain. This condition leads to a variety of motor and non-motor symptoms that can significantly impact the quality of life for those affected. Approximately 10 million people worldwide are living with Parkinson’s Disease, making it a significant public health concern^[1]. Understanding the underlying mechanisms, symptoms, and treatment options is essential for effectively managing this condition^[2,3].

Symptoms

The symptoms of Parkinson's Disease can be broadly categorized into motor and non-motor symptoms:

Motor Symptoms:

• Tremors: Often starting in one hand or foot, tremors are a common symptom of PD^[4].
• Bradykinesia: A slowing of movement that can affect the ability to perform daily tasks^[5].
• Rigidity: Increased stiffness in the arms and legs^[6].
• Postural Instability: Difficulty with balance and walking^[7].

Non-Motor Symptoms:

• Sleep Disturbances: Issues such as insomnia or excessive daytime sleepiness^[8].
• Cognitive Impairment: Difficulties with memory, attention, and problem-solving^[9].
• Mood Disorders: Conditions such as depression, anxiety, or mood swings^[10].
• Autonomic Dysfunction: Abnormalities in blood pressure, heart rate, and sweating^[11].

Current Treatment Options

While there is no cure for Parkinson's Disease, various treatment options can help manage symptoms and improve quality of life, including:

Medications

A variety of medications are available to treat motor symptoms, such as:

• Levodopa/Carbidopa: A combination medication that converts levodopa into dopamine in the brain^[12].
• Dopamine Agonists: Medications that stimulate dopamine receptors in the brain^[13].
• MAO-B Inhibitors: Medications that prevent the breakdown of dopamine in the brain^[14].
• Anticholinergic Medications: Medications that reduce muscle stiffness and tremors^[15].

Surgical Treatments

• Deep Brain Stimulation (DBS): A surgical procedure that can provide relief from motor symptoms^[16].
• Magnetic Resonance-Guided Focused Ultrasound (MRgFUS): A non-invasive procedure used to treat motor symptoms^[17].

Rehabilitation and Supportive Care

• Physical Therapy: Helps improve movement and strength^[18].
• Occupational Therapy: Assists in managing daily activities^[19].
• Speech Therapy: Addresses communication and swallowing difficulties^[20].
• Traditional Chinese Medicine (TCM): Various modalities can help manage non-motor symptoms and improve overall quality of life^[21].

Treatment Options at Beijing Puhua International Hospital

Our hospital offers a range of treatment options for Parkinson's Disease, including:

• Medications: We use the latest medications to manage motor symptoms, including levodopa/carbidopa, dopamine agonists, MAO-B inhibitors, and anticholinergic medications.

• Surgical Treatments: Our expert neurosurgeons perform deep brain stimulation (DBS) and magnetic resonance-guided focused ultrasound (MRgFUS) procedures to provide relief from motor symptoms.

• Rehabilitation and Supportive Care: We offer physical therapy, occupational therapy, speech therapy, and traditional Chinese medicine (TCM) modalities to help manage non-motor symptoms and improve overall quality of life.

References

1. Parkinson’s Foundation. (2022). Parkinson’s Disease Statistics.

2. Dorsey, E. R., et al. (2018). “The Global Burden of Parkinson’s Disease: A Systematic Review.” Movement Disorders.

3. Kalia, L. V., & Lang, A. E. (2015). “Parkinson’s Disease.” Lancet.

4. Jankovic, J. (2008). “Parkinson's Disease: Clinical Features and Diagnosis.” Journal of Neurology, Neurosurgery & Psychiatry.

5. Postuma, R. B., et al. (2015). “Identifying Prodromal Parkinson's Disease: A Systematic Review.” Movement Disorders.

6. Fahn, S., & Cohen, J. (1992). “The Neurology of Parkinson's Disease.” Clinical Neurology and Neurosurgery.

7. Sutherland, H. S., et al. (2019). “Postural Stability and Mobility in Patients with Parkinson’s Disease.” Clinical Neurophysiology.

8. Chahine, L. M., et al. (2020). “Sleep Disorders in Parkinson’s Disease.” Parkinsonism & Related Disorders.

9. Aarsland, D., et al. (2011). “Cognitive Impairment in Parkinson's Disease: Clinical, Pathophysiological, and Treatment Aspects.” Nature Reviews Neurology.

10. O'Sullivan, S. S., et al. (2009). “Non-motor Symptoms in Parkinson’s Disease.” Journal of Neurology, Neurosurgery & Psychiatry.

11. Schapira, A. H. V. (2008). “Mitochondria in the etiology and pathogenesis of Parkinson’s disease.” Movement Disorders.

12. Marsden, C. D. (1989). “The History of Parkinson's Disease.” Journal of Neurology.

13. Bhatia, K. P., & Marsden, C. D. (1994). “The Behavioral Neurology of Movement Disorders.” Movement Disorders.

14. LeWitt, P. A. (2015). “Levodopa for the Treatment of Parkinson’s Disease.” New England Journal of Medicine.

15. Olanow, C. W., et al. (2009). “Molecular Pathways for the Treatment of Parkinson’s Disease.” Movement Disorders.

16. Benabid, A. L., et al. (2009). “Deep Brain Stimulation for Parkinson's Disease.” Lancet Neurology.

17. Rachmany, L., et al. (2020). “MRI-guided Focused Ultrasound for Parkinson’s Disease: A Review.” Journal of Neuroimaging.

18. Awan, N. R., et al. (2016). “Role of Physiotherapy in Parkinson’s Disease: A Review.” Clinical Rehabilitation.

19. Matar, N., et al. (2016). “Occupational Therapy for Patients with Parkinson's Disease.” Journal of Rehabilitation Medicine.

20. O'Reilly, C., et al. (2019). “Speech Therapy in Parkinson’s Disease.” Journal of Neurology.

21. Lu, H., et al. (2013). “Traditional Chinese Medicine for Parkinson’s Disease: A Review.” Journal of Traditional Chinese Medicine.

22. Barker, R. A., et al. (2013). “Regenerative Medicine and Parkinson’s Disease.” Nature Reviews Neurology.

Patient Information:

• Name: Jorgan Vindfeldt
• Diagnosis: Prostate Cancer with Bone Metastasis
• Date of Birth (D.O.B): October 16, 1943
• Gender: Male
• Country: Denmark

Treatment: Comprehensive Anti-Cancer Treatment at Beijing Puhua International Hospital (BPIH)

• Optimized Chemotherapy
• DC-CIK Cellular Therapy
• Traditional Chinese Medicine (TCM)

Medical Condition Before Treatment:

70-year-old Mr. Jorgan Vindfeldt was recently admitted to BPIH after being diagnosed with prostate cancer and bone metastasis a year prior at a local hospital. He received endocrine therapy initially, but his condition stabilized without improvement in symptoms or bone metastasis, as indicated by stable PSA levels and bone scan results.

• Severe pain requiring frequent pain medication use
• Generalized feelings of depression and fatigue

Medical Condition After Treatment:

After completing two weeks of comprehensive anti-cancer treatment at BPIH:

• Significantly improved symptoms with minimal to no pain; no longer required pain medication
• Increased energy levels and overall well-being
• Improved mood, reporting feeling happier and more energetic compared to his pre-treatment condition